rs369587937
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_015474.4(SAMHD1):c.1324C>T(p.Arg442*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000151 in 1,461,038 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R442R) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_015474.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- Aicardi-Goutieres syndrome 5Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
- Moyamoya diseaseInheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
- Aicardi-Goutieres syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial chilblain lupusInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- chilblain lupus 2Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- chilblain lupusInheritance: AD Classification: NO_KNOWN Submitted by: Illumina
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SAMHD1 | NM_015474.4 | c.1324C>T | p.Arg442* | stop_gained | Exon 12 of 16 | ENST00000646673.2 | NP_056289.2 | |
| SAMHD1 | NM_001363729.2 | c.1324C>T | p.Arg442* | stop_gained | Exon 12 of 15 | NP_001350658.1 | ||
| SAMHD1 | NM_001363733.2 | c.1324C>T | p.Arg442* | stop_gained | Exon 12 of 16 | NP_001350662.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000796 AC: 2AN: 251408 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.0000151 AC: 22AN: 1461038Hom.: 0 Cov.: 30 AF XY: 0.0000220 AC XY: 16AN XY: 726892 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Aicardi-Goutieres syndrome 5 Pathogenic:1Other:1
- -
This sequence change creates a premature translational stop signal (p.Arg442*) in the SAMHD1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SAMHD1 are known to be pathogenic (PMID: 19525956, 22461318). This variant is present in population databases (rs369587937, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with Aicardi-Goutieres syndrome (PMID: 19525956). ClinVar contains an entry for this variant (Variation ID: 126406). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at